Combination therapy for the treatment of bacterial infections
The invention features a method for treating a subject diagnosed with, or at risk of developing, a bacterial infection by administering to the subject a combination of biologically active agents.
1. A shaped article comprising a composition wherein
said composition comprises a combination of a membrane active biocide that is a cationic biguanide antibacterial agent and a second agent selected from fluoroquinolones;
wherein said composition comprises a biodegradable polymer having a first repeating unit and a second repeating unit, said first repeating unit comprising a membrane active biocide that is a cationic biguanide antibacterial agent and said second repeating unit comprising an agent that is a fluoroquinolone, and
wherein said shaped article is in the form of an implantable medical device.
2. The shaped article of claim 1 , wherein said implantable medical device is a cardiac-assist device, a catheter, a stent, a prosthetic implant, a suture, a cuff, a mesh, a hernia patch, a wound dressing, a bandage, an artificial sphincter, or a drug delivery device.
3. The shaped article of claim 1 , wherein said membrane active biocide is chlorhexidine and said second agent is ciprofloxacin.
4. The shaped article of claim 2 , wherein said membrane active biocide is chlorhexidine and said second agent is ciprofloxacin.
5. The shaped article of claim 1 , wherein said membrane active biocide is chlorhexidine.
6. The shaped article of claim 1 , wherein said second agent is a fluoroquinolone selected from ciprofloxacin, enrofloxacin, enoxacin, gatifloxacin, gemifloxacin, levofloxacin, lomefloxacin, moxifloxacin, norfloxacin, ofloxacin, sparfloxacin, trovafloxacin, difloxacin, cinofloxacin, pefloxacin, tosufloxacin, temafloxacin, fleroxacin, amifloxacin, binfloxacin, danofloxacin, marbofloxacin, ruflocaxin, and sarafloxacin.